Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 we » 2 e (Expand Search), 2 de (Expand Search), _ we (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 we » 2 e (Expand Search), 2 de (Expand Search), _ we (Expand Search)
-
921
-
922
Decreased MBP levels in the brain in <i>Large</i><sup><i>myd/myd</i></sup> mice.
Published 2020“…The panels on the right are magnified images of the corpus callosum indicated by the squares in the panels on the left (Scale bars: 100 μm). Decreased immunoreactivity of MBP was observed in <i>Large</i><sup><i>myd/myd</i></sup> mice. …”
-
923
-
924
-
925
Effect of partial Glo-I inhibition by EP on LPS-induced production of TNF-α, collagen-I and α-SMA in HSC.
Published 2017“…Co-treatment of LPS and EP indicated significant dose-dependent reduction of LPS-induced markers of inflammation <b>(A1)</b> and fibrosis <b>(B1, C1)</b>. Presence of LPS and treatment with low-level concentrations of MGO (indicating partial inhibition of Glo-I activity without complete enzyme inhibition) showed significant decrease of LPS-induced release of TNF-α (absence vs. presence of 10mM MGO: 371.8±22.7 vs. 60.9±11.2 pg/ml; p<0.001), collagen-I (10.0±0.3 vs. 1.8±0.5 ng/ml; p<0.001) and α-SMA (68.6±3.6 vs. 43.8±2.2 ng/ml; p<0.001) <b>(A2, B2, C2)</b>. …”
-
926
-
927
-
928
Administration of APB5, but not APA5, decreases the hyperplasia of alveolar type 2 epithelial cells induced by BLM.
Published 2018“…The administration of APB5 markedly decreased the hyperplasia of type 2 epithelial cells induced by BLM. …”
-
929
-
930
-
931
-
932
-
933
-
934
-
935
-
936
-
937
Analysis of the <sup>1</sup>H–<sup>15</sup>N HSQC spectra of S100A1 in complex with the unlabeled S100B.
Published 2018“…</p> <p>(C) Bar plot presenting the decrease in the cross-peak intensity ratio (I/I<sub>0</sub>) of S100A1 and the S100A1-S100B complex. …”
-
938
S3 Data -
Published 2024“…Immunoblot showed a reduction in Jak2, the pSTAT3 to STAT 3 Ratio, pSMAD 2/3, and SMAD 2/3, and an increase in STAT 3 in the SIT group relative to CON (all p<0.05). …”
-
939
S1 Data -
Published 2024“…Immunoblot showed a reduction in Jak2, the pSTAT3 to STAT 3 Ratio, pSMAD 2/3, and SMAD 2/3, and an increase in STAT 3 in the SIT group relative to CON (all p<0.05). …”
-
940
S4 Data -
Published 2024“…Immunoblot showed a reduction in Jak2, the pSTAT3 to STAT 3 Ratio, pSMAD 2/3, and SMAD 2/3, and an increase in STAT 3 in the SIT group relative to CON (all p<0.05). …”